Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials.

Larocca A, Mina R, Offidani M, Liberati AM, Ledda A, Patriarca F, Evangelista A, Spada S, Benevolo G, Oddolo D, Innao V, Cangialosi C, Bernardini A, Musto P, Amico V, Fraticelli V, Paris L, Giuliani N, Falcone AP, Zambello R, De Paoli L, Romano A, Palumbo A, Montefusco V, Hajek R, Boccadoro M, Bringhen S.

Haematologica. 2019 Jun 27. pii: haematol.2019.220657. doi: 10.3324/haematol.2019.220657. [Epub ahead of print]

2.

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.

Conticello C, Romano A, Del Fabro V, Martino EA, Calafiore V, Sapienza G, Leotta V, Parisi MS, Markovic U, Garibaldi B, Leotta S, Cotzia E, Innao V, Mannina D, Neri S, Musso M, Scalone R, Cangialosi C, Acquaviva F, Cardinale G, Merenda A, Maugeri C, Uccello G, Poidomani M, Longo G, Carlisi M, Tibullo D, Di Raimondo F.

J Clin Med. 2019 Jun 19;8(6). pii: E877. doi: 10.3390/jcm8060877.

3.

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis.

Cerrato C, Di Raimondo F, De Paoli L, Spada S, Patriarca F, Crippa C, Mina R, Guglielmelli T, Ben-Yehuda D, Oddolo D, Nozzoli C, Angelucci E, Cascavilla N, Rizzi R, Rocco S, Baldini L, Ponticelli E, Marcatti M, Cangialosi C, Caravita T, Benevolo G, Ria R, Nagler A, Musto P, Tacchetti P, Corradini P, Offidani M, Palumbo A, Petrucci MT, Boccadoro M, Gay F.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19.

PMID:
29675792
4.

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD).

Terragna C, Remondini D, Martello M, Zamagni E, Pantani L, Patriarca F, Pezzi A, Levi G, Offidani M, Proserpio I, De Sabbata G, Tacchetti P, Cangialosi C, Ciambelli F, ViganĂ² CV, Dico FA, Santacroce B, Borsi E, Brioli A, Marzocchi G, Castellani G, Martinelli G, Palumbo A, Cavo M.

Oncotarget. 2016 Mar 1;7(9):9666-79. doi: 10.18632/oncotarget.5718.

5.

Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs.

Napolitano M, Saccullo G, Bono R, Branca A, Cangialosi C, Mancuso S, Raso S, Quintini G, Lipari MG, Fabbiano F, Specchia G, Dolce A, Di Raimondo F, Siragusa S.

Leuk Lymphoma. 2015 May;56(5):1507-9. doi: 10.3109/10428194.2014.955021. Epub 2014 Oct 7. No abstract available.

PMID:
25139690
6.

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival.

Ferrero S, Ladetto M, Drandi D, Cavallo F, Genuardi E, Urbano M, Caltagirone S, Grasso M, Rossini F, Guglielmelli T, Cangialosi C, Liberati AM, Callea V, Carovita T, Crippa C, De Rosa L, Pisani F, Falcone AP, Pregno P, Oliva S, Terragna C, Musto P, Passera R, Boccadoro M, Palumbo A.

Leukemia. 2015 Mar;29(3):689-95. doi: 10.1038/leu.2014.219. Epub 2014 Jul 16.

PMID:
25027515
7.

Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization.

Orciuolo E, Buda G, Marturano E, Mauro E, Milone G, Cangialosi C, Di Renzo N, Pastore D, Specchia G, De Paolis MR, Mazza P, Pietrantuono G, Petrini M.

Leuk Res. 2011 Jul;35(7):899-903. doi: 10.1016/j.leukres.2010.10.029. Epub 2010 Dec 4.

8.

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.

Bringhen S, Larocca A, Rossi D, Cavalli M, Genuardi M, Ria R, Gentili S, Patriarca F, Nozzoli C, Levi A, Guglielmelli T, Benevolo G, Callea V, Rizzo V, Cangialosi C, Musto P, De Rosa L, Liberati AM, Grasso M, Falcone AP, Evangelista A, Cavo M, Gaidano G, Boccadoro M, Palumbo A.

Blood. 2010 Dec 2;116(23):4745-53. doi: 10.1182/blood-2010-07-294983. Epub 2010 Aug 31. Erratum in: Blood. 2012 Dec 20;120(26):5250.

9.

Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma.

Ladetto M, Pagliano G, Ferrero S, Cavallo F, Drandi D, Santo L, Crippa C, De Rosa L, Pregno P, Grasso M, Liberati AM, Caravita T, Pisani F, Guglielmelli T, Callea V, Musto P, Cangialosi C, Passera R, Boccadoro M, Palumbo A.

J Clin Oncol. 2010 Apr 20;28(12):2077-84. doi: 10.1200/JCO.2009.23.7172. Epub 2010 Mar 22.

PMID:
20308672
10.

Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study.

Palumbo A, Bringhen S, Bruno B, Falcone AP, Liberati AM, Grasso M, Ria R, Pisani F, Cangialosi C, Caravita T, Levi A, Meloni G, Nozza A, Pregno P, Gabbas A, Callea V, Rizzo M, Annino L, De Stefano V, Musto P, Baldi I, Cavallo F, Petrucci MT, Massaia M, Boccadoro M.

Blood. 2010 Mar 11;115(10):1873-9. doi: 10.1182/blood-2009-09-241737. Epub 2009 Dec 1. Erratum in: Blood. 2010 Sep 23;116(12):2195.

11.

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.

Palumbo A, Ambrosini MT, Benevolo G, Pregno P, Pescosta N, Callea V, Cangialosi C, Caravita T, Morabito F, Musto P, Bringhen S, Falco P, Avonto I, Cavallo F, Boccadoro M; Italian Multiple Myeloma Network; Gruppo Italiano Malattie Ematologicche dell'Adulto.

Blood. 2007 Apr 1;109(7):2767-72.

12.

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.

Palumbo A, Bringhen S, Caravita T, Merla E, Capparella V, Callea V, Cangialosi C, Grasso M, Rossini F, Galli M, Catalano L, Zamagni E, Petrucci MT, De Stefano V, Ceccarelli M, Ambrosini MT, Avonto I, Falco P, Ciccone G, Liberati AM, Musto P, Boccadoro M; Italian Multiple Myeloma Network, GIMEMA.

Lancet. 2006 Mar 11;367(9513):825-31.

PMID:
16530576
13.

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

Palumbo A, Bertola A, Musto P, Caravita T, Callea V, Nunzi M, Grasso M, Falco P, Cangialosi C, Boccadoro M.

Cancer. 2005 Oct 1;104(7):1428-33.

14.

All-trans retinoic acid induced cardiac and skeletal myositis in induction therapy of acute promyelocytic leukaemia.

Fabbiano F, Magrin S, Cangialosi C, Felice R, Mirto S, Pitrolo F.

Br J Haematol. 2005 May;129(3):444-5. No abstract available.

PMID:
15842672
15.

Podiatric manifestations in patients with acute and chronic neurologic disorders.

Cangialosi CP.

Clin Podiatry. 1985 Oct;2(4):611-30.

PMID:
4075555
16.

Infections in minimal incision surgery.

Cangialosi CP.

Clin Podiatry. 1985 Jul;2(3):435-47.

PMID:
4028487
17.

Plantar keratoses. Why treatment often fails and what to do about it.

Cangialosi CP.

Postgrad Med. 1984 Mar;75(4):128-9. No abstract available.

PMID:
6199781
18.

Aquatic contact dermatitis. Report of two cases.

Cangialosi CP.

J Am Podiatry Assoc. 1983 Jan;73(1):21-4. No abstract available.

PMID:
6130111
19.

Podiatric anesthesia revisited.

Cangialosi CP.

J Am Podiatry Assoc. 1982 Sep;72(9):448-52. No abstract available.

PMID:
7108114
20.

Synthetic skin. A new adjunct in the treatment of diabetic ulcers.

Cangialosi CP.

J Am Podiatry Assoc. 1982 Jan;72(1):48-52. No abstract available.

PMID:
7054269
21.

The podiatric history and physical examination as an effective diagnostic tool.

Cangialosi CP.

J Foot Surg. 1982 Summer;21(2):146-52. Review. No abstract available.

PMID:
7047630
22.

Pedal spider bite (arachnidism): report of two similar cases.

Cangialosi CP, Schnall SJ.

J Am Podiatry Assoc. 1981 Jul;71(7):385-7. No abstract available.

PMID:
7264153
23.

Treatment of forefoot valgus (nontotal): a new surgical approach by split extensor hallucis longus tendon transfer.

Cangialosi CP.

J Foot Surg. 1981 Spring;20(1):21-4. No abstract available.

PMID:
7347340
24.

Ruptured anterior talofibular ligament: a simplified procedure for late repair.

Cangialosi CP.

J Foot Surg. 1981 Winter;20(4):224-6.

PMID:
7033338
25.

The biomechanical aspects of anterior tarsal tunnel syndrome.

Cangialosi CP, Schnall SJ.

J Am Podiatry Assoc. 1980 Jun;70(6):291-2. No abstract available.

PMID:
7381141
26.

Primary epidermoid carcinoma of the foot: report of a case.

Cangialosi CP.

J Am Podiatry Assoc. 1978 Oct;68(10):691-2. No abstract available.

PMID:
690377
27.

Surgical shoe reuse. A microbiological experiment.

Cangialosi CP, Carroll DJ.

J Am Podiatry Assoc. 1977 Nov;67(11):788-9. No abstract available.

PMID:
915188
28.

Compressive occlusion of the posterior tibial artery: an unusual case report.

Cangialosi CP.

J Foot Surg. 1977 Winter;16(4):161-2. No abstract available.

PMID:
611141
29.

Kaposi's sarcoma of the foot. A case report.

Cangialosi CP, Schnall SJ.

J Am Podiatry Assoc. 1976 Jul;66(7):525-7. No abstract available.

PMID:
932396
30.

Surgical correction of congenital bilateral simple syndactylism. A case report.

Cangialosi CP, Polito MA.

J Am Podiatry Assoc. 1975 May;65(5):465-71. No abstract available.

PMID:
164496

Supplemental Content

Loading ...
Support Center